Epocrates Drug Updates - Editor's Pick

August 14, 2014
Zydelig Approved for Three Types of Blood Cancers

The FDA recently approved Zydelig (idelalisib) for the treatment of three types of relapsed blood cancers: chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL), and small lymphocytic lymphoma (SLL). Zydelig is an oral phosphatidylinositol 3-kinase (PI3K) inhibitor and has a Boxed Warning for hepatotoxicity, severe diarrhea or colitis, pneumonitis, and intestinal perforation.

Zydelig Approved for Three Types of Blood Cancers

Recent Updates

August 8, 2014
Beleodaq Approved for Relapsed or Refractory Peripheral T-cell Lymphoma
The FDA recently approved Beleodaq (belinostat), a new histone deacetylase (HDAC) inhibitor for the treatment of relapsed or refractory peripheral T-cell lymphoma. Beleodaq is given as an IV infusion once daily for 5 days each cycle.
Beleodaq Approved for Relapsed or Refractory Peripheral T-cell Lymphoma

July 24, 2014
Zontivity (Oral PAR-1 Inhibitor) Approved for Thrombotic Cardiovascular Events
The FDA recently approved Zontivity (vorapaxar), a once-daily, first-in-class protease-activated receptor-1 (PAR-1) antagonist for the prevention of heart attack and stroke in patients with peripheral arterial disease or a history of myocardial infarction.
Zontivity (Oral PAR-1 Inhibitor) Approved for Thrombotic Cardiovascular Events

July 17, 2014
Dalvance Approved for Acute Bacterial Skin and Skin Structure Infections in Adults
The FDA recently approved Dalvance (dalbavancin), a new lipoglycopeptide antibacterial for skin and skin structure infections caused by certain gram-positive microorganisms, including methicillin-resistant Staphylococcus aureus (MRSA). Dalvance is available as an IV infusion, and is given once weekly for 2 consecutive weeks.
Dalvance Approved for Acute Bacterial Skin and Skin Structure Infections in Adults

July 10, 2014
FDA MedWatch Safety Alert for Docetaxel
The FDA recently warned that docetaxel products contain ethanol (alcohol), potentially causing patients to feel intoxicated during and after treatment. Providers should consider the ethanol content when prescribing or administering docetaxel, particularly in patients in whom alcohol intake should be avoided or minimized, and when used with concomitant medications.
FDA MedWatch Safety Alert for Docetaxel

July 3, 2014
Sivextro Approved for Acute Bacterial Skin and Skin Structure Infections in Adults
The FDA recently approved Sivextro (tedizolid phosphate), a new oxazolidinone antibacterial for skin and skin structure infections caused by certain gram-positive microorganisms, including methicillin-resistant Staphylococcus aureus (MRSA). Sivextro is given once daily for 6 days, and can be administered orally or by IV infusion.
Sivextro Approved for Acute Bacterial Skin and Skin Structure Infections in Adults

New Drug Monographs

What is an RSS Feed?

From Wikipedia: "RSS is a simple XML-based system that allows users to subscribe to their favorite websites. Using RSS, webmasters can put their content into a standardized format, which can be viewed and organized through RSS-aware software or automatically conveyed as new content on another website."

email Subscribe by email

Enter your email address:


   Cancel

Delivered by FeedBurner